Noninvasive versus histologic detection of gastric atrophy in a hispanic population in North America

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 3, 2006, Pages 306-314

  Graham, David Y ^a   Nurgalieva, Zhannat Z ^a   El Zimaity, Hala M T ^a   Opekun, Antone R ^a   Campos, Armando ^c   Guerrero, Leoncio ^c   Chavez, Alfredo ^c   Cardenas, Victor ^b,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c Regional General Hospital   (Mexico)

^d UT School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN 17; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISPANIC; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORTH AMERICA; SEROLOGY; STOMACH BIOPSY; STOMACH CARCINOMA;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ATROPHY; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTROSCOPY; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MEXICO; MIDDLE AGED; PEPSINOGENS; SEROLOGIC TESTS;

EID: 33644752613     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2005.11.003     Document Type: Article

References (34)

1. D.Y. Graham Helicobacter pylori infection is the primary cause of gastric cancer J Gastroenterol 35 Suppl 12 2000 90 97
2. P. Sipponen, M. Kekki, J. Haapakoski Gastric cancer risk in chronic atrophic gastritis statistical calculations of cross-sectional data Int J Cancer 35 1985 173 177
3. A. Oshima Secondary prevention screening methods in high-incidence areas T. Sugimura M. Sasako Gastric cancer 1997 Oxford University Press Oxford 199 212
4. K. Aoki, J. Misumi, T. Kimura Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study J Epidemiol 7 1997 143 151
5. H. Fukuda, D. Saito, S. Hayashi Helicobacter pylori infection, serum pepsinogen level and gastric cancer a case-control study in Japan Jpn J Cancer Res 86 1995 64 71
6. Y. Hattori, H. Tashiro, T. Kawamoto Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens Jpn J Cancer Res 86 1995 1210 1215
7. F. Kitahara, K. Kobayashi, T. Sato Accuracy of screening for gastric cancer using serum pepsinogen concentrations Gut 44 1999 693 697
8. K. Miki, M. Ichinose, K.B. Ishikawa Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer Jpn J Cancer Res 84 1993 1086 1090
9. A. Shiotani, H. Iishi, N. Uedo Histologic and serum risk markers for noncardia early gastric cancer Int J Cancer 115 2005 463 469
10. K. Miki, M. Ichinose, A. Shimizu Serum pepsinogens as a screening test of extensive chronic gastritis Gastroenterol Jpn 22 1987 133 141
11. M. Kekki, I.M. Samloff, K. Varis Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis Scand J Gastroenterol Suppl 186 1991 109 116
12. K. Varis, M. Kekki, M. Harkonen Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer Scand J Gastroenterol Suppl 186 1991 117 123
13. D.Y. Graham Helicobacter pylori and perturbations in acid secretion the end of the beginning Gastroenterology 110 1996 1647 1650
14. D.Y. Graham, M.P. Dore Perturbations in gastric physiology in Helicobacter pylori duodenal ulcer are they all epiphenomena? Helicobacter 2 Suppl 1 1997 S44 S49
15. D.Y. Graham, J.E. McGuigan Interactions between gastrin, gastric secretion, and Helicobacter pylori in health and disease Y. Tache Y. Goto G. Ohning T. Yamada Gut-brain peptides in the new millenium 2002 Cure Foundation Los Angeles 83 101
16. H.M. El-Zimaity, D.Y. Graham, M.T. Al-Assi Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis Hum Pathol 27 1996 35 41
17. M. Rugge, P. Correa, M.F. Dixon Gastric mucosal atrophy interobserver consistency using new criteria for classification and grading Aliment Pharmacol Ther 16 2002 1249 1259
18. H.M. El-Zimaity, H. Ota, D.Y. Graham Patterns of gastric atrophy in intestinal type gastric carcinoma Cancer 94 2002 1428 1436
19. O. Ricuarte, O. Gutierrez, H. Cardona Atrophic gastritis in young children and adolescents J Clin Pathol 58 2005 1189 1193
20. K. Kimura Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach Gastroenterology 63 1972 584 592
21. K. Kimura, T. Takemoto An endoscopic recognition of the atrophic border and its significance in chronic gastritis Endoscopy 1 1969 87 97
22. S.E. Miederer, F. Paul, O. Stadelmann Pyloric-kardiate expansion der gastritis Endoscopy 1 1969 170 174
23. K. Kimura, K. Satoh, K. Ido Gastritis in the Japanese stomach Scand J Gastroenterol Suppl 214 1996 17 20
24. K. Satoh, K. Kimura, Y. Taniguchi Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis Am J Gastroenterol 91 1996 963 969
25. P. Sipponen, P. Ranta, T. Helske Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis an observational case-control study Scand J Gastroenterol 37 2002 785 791
26. D.Y. Graham Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer a model Gastroenterology 113 1997 1983 1991
27. D.Y. Graham, A. Shiotani The time to eradicate gastric cancer is now Gut 54 2005 735 738
28. P. Sipponen, M. Harkonen, A. Alanko Diagnosis of atrophic gastritis from a serum sample Clin Lab 48 2002 505 515
29. M. Hartleb, P. Wandzel, M. Waluga Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies Acta Gastroenterol Belg 67 2004 320 326
30. V.D. Pasechnikov, S.Z. Chukov, S.M. Kotelevets Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis a comparative study Scand J Gastroenterol 40 2005 297 301
31. C. Ricci, N. Vakil, M. Rugge Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori Am J Gastroenterol 99 2004 1910 1915
32. H. Vaananen, M. Vauhkonen, T. Helske Non-endoscopic diagnosis of atrophic gastritis with a blood test: correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study Eur J Gastroenterol Hepatol 15 2003 885 891
33. M.T. Hallissey, J.A. Dunn, J.W. Fielding Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions Scand J Gastroenterol 29 1994 1129 1134
34. H. Suzuki, T. Masaoka, H. Hosoda Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio a possible novel and non-invasive marker for gastric atrophy Hepatogastroenterology 51 2004 1249 1254